{{Main article|Estradiol (medication)#Adverse effects}}

 


 
Estradiol undecylate has been used at very high dosages in the treatment of prostate cancer. At these high dosages, it has been associated with a considerable incidence of cardiovascular complications.<ref name="WenderothJacobi1983">{{cite journal|last1=Wenderoth|first1=U. K.|last2=Jacobi|first2=G. H.|title=Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate|journal=World Journal of Urology|volume=1|issue=1|year=1983|pages=40â€“48|issn=0724-4983|doi=10.1007/BF00326861}}</ref> In a 6-month study of 25 patients administered 100&nbsp;mg/month intramuscular estradiol undecylate for the treatment of prostate cancer, it was reported that 8 cases of severe cardiovascular complications, including 2 deaths, occurred.<ref name="WenderothJacobi1983" />

 

